Skip to main content


Current Hematologic Malignancy Reports

Current Hematologic Malignancy Reports OnlineFirst articles

07.03.2018 | T-Cell and Other Lymphoproliferative Malignancies (J Zain, Section Editor)

Update on the Treatment of Anaplastic Large Cell Lymphoma

Anaplastic large cell lymphoma (ALCL) is a subtype of peripheral T cell lymphoma (PTCL) that is characterized by large CD30+ anaplastic cells that often have horseshoe- or kidney-shaped nuclei, grow in cohesive sheets, and infiltrate lymph node …

27.02.2018 | Health Economics (N Khera, Section Editor)

Value-Based Care in Hematopoietic Cell Transplantation and Cellular Therapy: Challenges and Opportunities

Over 20,000 hematopoietic cell transplantations (HCT) are performed annually in the USA and are often the only known curative therapy for some patients with high-risk malignant and non-malignant hematologic diseases. In addition, chimeric antigen …

26.02.2018 | Chronic Lymphocytic Leukemias (N Jain, Section Editor)

Frontline Therapy of CLL: Evolving Treatment Paradigm

Chronic lymphocytic leukemia (CLL) is a malignancy of B lymphocytes and the most common leukemia in adults. In the USA, there were an estimated 20,110 new cases of CLL and 4660 deaths related to CLL in 2017. The risk of developing CLL increases …

23.02.2018 | Chronic Lymphocytic Leukemias (N Jain, Section Editor)

Prognostic Factors in the Era of Targeted Therapies in CLL

Chronic lymphocytic leukemia (CLL) is characterized by clinically variable course, with disease presentation ranging from indolent asymptomatic lymphocytosis to advanced-staged disease with associated complications. The heterogeneity in clinical …

15.02.2018 | Multiple Myeloma (P Kapoor, Section Editor)

Common Adverse Effects of Novel Therapies for Multiple Myeloma (MM) and Their Management Strategies

Multiple myeloma (MM) is expected to account for approximately 1.8% of new malignancies and 10% of all hematologic malignancies diagnosed in 2018 [ 1 ]. Although it remains incurable, the past two decades have brought substantial advancements in …

Aktuelle Ausgaben

Über diese Zeitschrift

Current Hematologic Malignancy Reports provides in-depth review articles contributed by international experts on the most significant developments in the field. By presenting clear, insightful, balanced reviews that emphasize recently published papers of major importance, the journal elucidates current and emerging approaches to the diagnosis, treatment, management, and prevention of conditions associated with hematologic malignancy.

Weitere Informationen

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.